|
Mobile version
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
US Oncological Review Volume 6 Touch Briefings Share     In this issue, Dr. Jean-Pierre provides an update about the management of cancer-related cognitive dysfunction (CRCD) and the challenges and implications for clinical research and practice. Dr. Ajay Gupta confirmed that high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) results in improved outcomes in multiple myeloma (MM) patients. Dr. Steven E. Schild discusses the survival of patients suffering from unresectable NSCLC who are treated with high-dose radiotherapy (RT) and concurrent chemotherapy. The feasibility of thermal infrared imaging screening for breast cancer in Southern Mexico is discussed by Dr. Gutierez-Delgado. ASCLS members can access the current edition U.S. Oncological Review Volume 6 in full and for free in eBook format. Members please login, return to this page and click the journal image to access the e-book. (Click through to provide link http://www.touchbriefings.com/ebooks/A1pps5/usoncvol6/) More
MRI superior in detecting early cancer in high-risk women Medscape Medical News Share
Magnetic resonance imaging (MRI) appears to be more effective than mammography in detecting early breast cancer in women at high risk for breast cancer. Dutch researchers found that with a follow-up period of approximately five years, the sensitivity of MRI is still superior to that of mammography in women with BRCA mutations. More FDA approves second trial of stem-cell therapy TIME magazine Share
For only the second time, the Food and Drug Administration approved a company's request to test an embryonic stem cell-based therapy on human patients. Advanced Cell Technology (ACT), based in Marlborough, Mass., will begin testing its retinal cell treatment this year in a dozen patients with Stargardt's macular dystrophy, an inherited degenerative eye disease that leads to blindness in children. In July, the FDA released its hold on the first trial of an embryonic stem cell based treatment, for spinal cord injury. More Age-related IgE levels on the rise in the United States Medscape Medical News Share
Age-related immunoglobulin (Ig)E levels have risen significantly in both males and females in the United States since the 1970s, researchers announced at the American College of Allergy, Asthma & Immunology (ACAAI) 2010 Annual Scientific Meeting. The finding might be the reason for the increase in allergic rhinitis, asthma, and allergies in general that are being seen today, said Zackary Jacobs, MD, from Children's Mercy Hospitals and Clinics, Kansas City, Mo. More Syphilis infections up; progress made on other STDs CNN Health Share
A decade ago, the sexually transmitted disease syphilis was on the verge of elimination. Today, a new study by the U.S. Centers for Disease Control and Prevention shows a 39 percent increase in the disease from 2006 to 2009, with most new cases appearing in young black men. "The majority of the increase is amongst men who have sex with men," said Charlotte Kent, acting director of the CDC's division of STD prevention. The CDC called the increase a concerning new trend. More
Febrile infants with UTI may be at low risk for adverse events, bacteremia Medscape Medical News Share
Brief hospitalization or close outpatient management and follow-up may be considered for infants with urinary tract infections (UTIs) who are at very low risk for adverse events and bacteremia, according to the results of a retrospective review study reported in the December issue of Pediatrics. More Kidney transplants found safe in HIV patients Reuters Share
People infected with HIV can safely receive a kidney transplant, researchers reported. The finding, published in the New England Journal of Medicine, is good news for people with the virus, who are more prone to kidney disease, in part because of the drugs they must take to stay healthy. More Uniform tracking standard will revolutionize health care purchasing nationwide Dark Daily Share
global location numbers (GLNs) will occur in just a few months. Every health care provider in the United States and many other nations will get a unique GLN. The entire purchasing and shipping side of health care is poised to adopt a universal standard that will ensure the precise delivery of products to their final destinations. Clinical laboratories and anatomic pathology groups will no longer experience delays caused by lost or incorrectly delivered supplies. At least that's the hope of most of the nation’s major group purchasing organizations. More |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||
